Voya Investment Management LLC Clovis Oncology, Inc. Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.96 $26,417 - $124,118	-41,932 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.7 - $4.76 $4,749 - $8,372	-1,759 Reduced 4.03%	41,932 $114,000
Q3 2021 Nov 15, 2021	BUY	$4.06 - $5.8 $16,633 - $23,762	4,097 Added 10.35%	43,691 $195,000
Q2 2021 Aug 16, 2021	BUY	$5.02 - $7.05 $18,518 - $26,007	3,689 Added 10.27%	39,594 $230,000
Q1 2021 May 17, 2021	BUY	$4.81 - $10.34 $6,406 - $13,772	1,332 Added 3.85%	35,905 $252,000
Q4 2020 Feb 16, 2021	BUY	$4.13 - $6.41 $28,005 - $43,466	6,781 Added 24.4%	34,573 $166,000
Q3 2020 Nov 16, 2020	BUY	$4.82 - $7.72 $12,960 - $20,759	2,689 Added 10.71%	27,792 $162,000
Q2 2020 Aug 14, 2020	BUY	$5.69 - $9.69 $2,264 - $3,856	398 Added 1.61%	25,103 $169,000
Q4 2019 Feb 14, 2020	BUY	$3.0 - $16.43 $13,962 - $76,465	4,654 Added 23.21%	24,705 $258,000
Q3 2019 Nov 14, 2019	SELL	$3.93 - $15.35 $1.41 Million - $5.49 Million	-357,726 Reduced 94.69%	20,051 $79,000
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $951,808 - $1.91 Million	74,302 Added 24.48%	377,777 $5.62 Million
Q1 2019 May 15, 2019	SELL	$17.66 - $30.28 $7.66 Million - $13.1 Million	-433,713 Reduced 58.83%	303,475 $7.53 Million
Q4 2018 Feb 14, 2019	SELL	$11.63 - $32.67 $330,664 - $928,873	-28,432 Reduced 3.71%	737,188 $13.2 Million
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $3.64 Million - $6.14 Million	124,050 Added 19.34%	765,620 $22.5 Million
Q2 2018 Aug 14, 2018	BUY	$42.06 - $62.4 $4.38 Million - $6.5 Million	104,114 Added 19.37%	641,570 $29.2 Million
Q1 2018 May 15, 2018	BUY	$50.12 - $67.72 $5.19 Million - $7.01 Million	103,457 Added 23.84%	537,456 $28.4 Million
Q4 2017 Feb 14, 2018	BUY	$57.69 - $84.58 $1.33 Million - $1.94 Million	22,989 Added 5.59%	433,999 $29.5 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $27.6 Million - $34.9 Million	411,010	411,010 $33.9 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account